Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Cash from Operations (2016 - 2026)

Champions Oncology has reported Cash from Operations over the past 17 years, most recently at 1339000.0 for Q1 2026.

  • Quarterly results put Cash from Operations at 1339000.0 for Q1 2026, down 373.27% from a year ago — trailing twelve months through Jan 2026 was 4394000.0 (up 438.52% YoY), and the annual figure for FY2025 was 7386000.0, up 220.35%.
  • Cash from Operations for Q1 2026 was 1339000.0 at Champions Oncology, up from 1735000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for CSBR hit a ceiling of 6868000.0 in Q2 2025 and a floor of 3991000.0 in Q3 2023.
  • Median Cash from Operations over the past 5 years was 311000.0 (2024), compared with a mean of 458823.53.
  • Biggest five-year swings in Cash from Operations: surged 3053.33% in 2022 and later tumbled 1946.67% in 2023.
  • Champions Oncology's Cash from Operations stood at 3286000.0 in 2022, then plummeted by 82.08% to 589000.0 in 2023, then tumbled by 148.05% to 283000.0 in 2024, then tumbled by 513.07% to 1735000.0 in 2025, then rose by 22.82% to 1339000.0 in 2026.
  • The last three reported values for Cash from Operations were 1339000.0 (Q1 2026), 1735000.0 (Q4 2025), and 600000.0 (Q3 2025) per Business Quant data.